½ÃÀ庸°í¼­
»óǰÄÚµå
1262908

¼¼°èÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå ¸®Æ÷Æ®(2023³â)

In-Vitro Toxicology Testing Global Market Report 2023

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀåÀº 2022³â 93¾ï 1,000¸¸ ´Þ·¯¿¡¼­ 2023³â¿¡´Â 103¾ï 5,000¸¸ ´Þ·¯·Î, CAGR 11.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ·¯½Ã¾Æ¡¤¿ìÅ©¶óÀ̳ª ÀüÀïÀº Àû¾îµµ ´Ü±âÀûÀ¸·Î´Â COVID-19 ÆÒµ¥¹ÍÀ¸·ÎºÎÅÍ ¼¼°è °æÁ¦ ȸº¹ÀÇ °¡´É¼ºÀ» È¥¶õ½ÃÄ×½À´Ï´Ù. ÀÌ µÎ ±¹°¡°£ ÀüÀïÀº º¹¼ö ±¹°¡¿¡ ´ëÇÑ °æÁ¦ Á¦Àç, »óǰ °¡°ÝÀÇ »ó½Â, °ø±Þ¸Á È¥¶õÀ¸·Î À̾îÁö¸ç, »óǰ ¹× ¼­ºñ½º Àüü¿¡ ÀÎÇ÷¹À̼ÇÀ» ÀÏÀ¸Å°°í, Àü ¼¼°èÀÇ ¸¹Àº ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ü¿Ü µ¶¹° °Ë»ç ½ÃÀåÀº CAGR 10.4%·Î 2027³â¿¡´Â 153¾ï 6,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

2022³â ½ÃÇè°ü³» µ¶¼º °Ë»ç ½ÃÀå¿¡¼­´Â ºÏ¹Ì°¡ ÃÖ´ë Áö¿ªÀÌ µÇ¾ú½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ Áß °¡Àå ±Þ¼ÓÈ÷ ¼ºÀåÇÏ´Â Áö¿ªÀÌ µÉ Àü¸ÁÀÔ´Ï´Ù. in vitro toxicology testing ½ÃÀå ¸®Æ÷Æ®ÀÇ ´ë»ó Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ¼­À¯·´, ÁßÀ¯·´ ¹× µ¿À¯·´, ºÏ¹Ì, ³²¹Ì, Áßµ¿¡¤¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀåÀÇ Æ¯Â¡

Á¦3Àå ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀåÀÇ µ¿Çâ°ú Àü·«

Á¦4Àå ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

  • ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ
  • ¿ìÅ©¶óÀ̳ª¿Í ·¯½Ã¾ÆÀÇ ÀüÀïÀÌ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå¿¡ ´ëÇÑ °íÀÎÇ÷¹À̼ÇÀÇ ¿µÇâ

Á¦5Àå ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

  • ¼¼°èÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå ½ÇÀû, 2017-2022³â
    • ½ÃÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¾ïÁ¦¿äÀÎ
  • ¼¼°èÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå ¿¹Ãø, 2022-2027F, 2032F
    • ½ÃÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¾ïÁ¦¿äÀÎ

Á¦6Àå ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç°°ú ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼Ò¸ðǰ
  • ¾î¼¼ÀÌ
  • Àåºñ
  • ¼ÒÇÁÆ®¿þ¾î
  • ¼­ºñ½º
  • ¼¼°èÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¹æ¹ýº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼¼Æ÷ ¾î¼¼ÀÌ
  • »ýÈ­ÇÐ ¾î¼¼ÀÌ
  • ÀνǸ®ÄÚ ¸ðµ¨
  • Ex Vivo ¸ðµ¨
  • ¼¼°èÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ±â¼úº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼¼Æ÷¹è¾ç ±â¼ú
  • ÇÏÀ̽º·çDz(High throughput) ±â¼ú
  • µ¶¼ºÀ¯ÀüüÇÐ
  • ¼¼°èÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾ÖÇø®ÄÉÀ̼Ǻ° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ½Å°æ µ¶¼º
  • ÇǺΠµ¶¼º
  • ¼¼Æ÷µ¶¼º
  • ±âŸ ¾ÖÇø®ÄÉÀ̼Ç
  • ¼¼°èÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀǾàǰ ¹× ¹ÙÀÌ¿ÀÀǾàǰ
  • È­Àåǰ¡¤°¡Á¤¿ëǰ
  • ½Äǰ
  • È­ÇÐÁ¦Ç°

Á¦7Àå ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå Áö¿ª ¹× ±¹°¡ ºÐ¼®

  • ¼¼°èÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Áö¿ªº°, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼¼°èÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ±¹°¡º°, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå °³¿ä
  • Áö¿ª Á¤º¸, COVID-19ÀÇ ¿µÇâ, ½ÃÀå Á¤º¸, ¹è°æ Á¤º¸, Á¤ºÎ ±¸»ó, ±ÔÁ¦, ±ÔÁ¦±â°ü, ÁÖ¿ä ´Üü, °ú¼¼µÇ´Â ¼¼, ¹ýÀμ¼ ±¸Á¶, ÅõÀÚ, ÁÖ¿ä ±â¾÷
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç°°ú ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦9Àå Áß±¹ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • Áß±¹ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå °³¿ä
  • Áß±¹ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç°°ú ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Áß±¹ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦10Àå ÀεµÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • ÀεµÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç°°ú ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀεµÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦11Àå ÀϺ»ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • ÀϺ»ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç° ¹× ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀϺ»ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦12Àå È£ÁÖÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • È£ÁÖÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç° ¹× ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • È£ÁÖÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦13Àå Àεµ³×½Ã¾ÆÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • Àεµ³×½Ã¾ÆÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç°°ú ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Àεµ³×½Ã¾ÆÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦14Àå Çѱ¹ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • Çѱ¹ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç° ¹× ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Çѱ¹ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦15Àå ¼­À¯·´ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • ¼­À¯·´ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå °³¿ä
  • ¼­À¯·´ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç°°ú ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼­À¯·´ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦16Àå ¿µ±¹ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • ¿µ±¹ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç°°ú ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¿µ±¹ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦17Àå µ¶ÀÏÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • µ¶ÀÏÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç°°ú ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • µ¶ÀÏÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦18Àå ÇÁ¶û½ºÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • ÇÁ¶û½ºÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç°°ú ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÇÁ¶û½ºÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦19Àå µ¿À¯·´ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • µ¿À¯·´ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå °³¿ä
  • µ¿À¯·´ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç°°ú ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • µ¿À¯·´ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦20Àå ·¯½Ã¾ÆÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • ·¯½Ã¾ÆÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç°°ú ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ·¯½Ã¾ÆÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦21Àå ºÏ¹ÌÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • ºÏ¹ÌÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå °³¿ä
  • ºÏ¹ÌÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç°°ú ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ºÏ¹ÌÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦22Àå ¹Ì±¹ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • ¹Ì±¹ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå °³¿ä
  • ¹Ì±¹ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç° ¹× ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¹Ì±¹ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦23Àå ³²¹ÌÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • ³²¹ÌÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå °³¿ä
  • ³²¹ÌÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç°°ú ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ³²¹ÌÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦24Àå ºê¶óÁúÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • ºê¶óÁúÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç°°ú ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ºê¶óÁúÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦25Àå Áßµ¿ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • Áßµ¿ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå °³¿ä
  • Áßµ¿ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç°°ú ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Áßµ¿ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦26Àå ¾ÆÇÁ¸®Ä«ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå

  • ¾ÆÇÁ¸®Ä«ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå °³¿ä
  • ¾ÆÇÁ¸®Ä«ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, Á¦Ç°°ú ¼­ºñ½ºº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¾ÆÇÁ¸®Ä«ÀÇ ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀå, ¾÷°èº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦27Àå ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀåÀÇ °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

  • ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀåÀÇ °æÀï ±¸µµ
  • ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀåÀÇ ±â¾÷ °³¿ä
    • Thermo Fisher Scientific Inc
    • Merck KGaA
    • Laboratory Corporation of America Holdings
    • Gentronix Limited
    • Bio-Rad Laboratories Inc

Á¦28Àå ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀåÀÇ ÁÖ¿ä ÇÕº´°ú Àμö

Á¦29Àå ÀκñÆ®·Î µ¶¼º ½ÃÇè ½ÃÀåÀÇ ¹Ì·¡ Àü¸Á°ú ÀáÀçÀû ºÐ¼®

Á¦30Àå ºÎ·Ï

KSA 23.04.27

“In-Vitro Toxicology Testing Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in-vitro toxicology testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in-vitro toxicology testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The in-vitro toxicology testing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product and Service: Consumables; Assays; Equipment; Software; Services
  • 2) By Method: Cellular Assays; Biochemical Assays; In Silico Models; Ex Vivo Models
  • 3) By Technology: Cell Culture Technologies; High-throughput Technologies; Toxicogenomics
  • 4) By Applications: Neurotoxicity; Dermal toxicity; Cytotoxicity; Other Applications
  • 5) By Industry: Pharmaceuticals and Biopharmaceuticals; Cosmetic and Household Products; Food; Chemicals
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Laboratory Corporation of America Holdings; Gentronix Limited; Bio-Rad Laboratories Inc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the in-vitro toxicology testing market are: Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings, Gentronix Limited, Bio-Rad Laboratories Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., Promega Corporation, Agilent Technologies Inc., Abbott Laboratories, Evotec AG, SGS S.A, BioIVT, MB Research Laboratories, Creative Biolabs Inc., Quest Diagnostics Inc., Creative Bioarray, InSphero AG, PerkinElmer Inc., and Cyprotex PLC.

The global in-vitro toxicology testing market is expected to grow from $9.31 billion in 2022 to $10.35 billion in 2023 at a compound annual growth rate (CAGR) of 11.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The in-vitro toxicology market is expected to grow to $15.36 billion in 2027 at a CAGR of 10.4%.

The in-vitro toxicology testing market includes revenues earned by entities by providing metabolic, toxicokinetic, and bioanalytical investigations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

In-vitro toxicology testing refers to assays and tests used to determine toxic doses of drugs, nutraceuticals, and food additives that cause toxicity when administered. It is used to detect the presence of toxic chemicals, and residual solvent, and reduce hazardous exposure. This testing is mostly used to determine the doses of medications that exhibit toxicity in preclinical development, along with drug discovery and development.

North America was the largest region in the in- vitro toxicology testing market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in- vitro toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main products of in-vitro toxicology testing are consumables, assays, equipment, software, and services. Consumables refer to all the products that are used in laboratory testing of compounds such as cannulas and lancets. The methods involved cellular assays, biochemical assays, in silico models, and ex vivo models, and technologies involved are cell culture technologies, high-throughput technologies, and toxicogenomic, applied under various application involving neurotoxicity, dermal toxicity, cytotoxicity, and other applications. The various industry verticals included pharmaceuticals and biopharmaceuticals, cosmetic and household products, food, and chemicals.

Growing healthcare expenditure is expected to propel the in-vitro toxicology testing market going forward. Health expenditure is the amount of money spent by citizens and the government out of total income on hospitals, home health services, prescription pharmaceuticals, nursing facilities, and personal healthcare. Health expenditure is increasing in the world due to the rising prevalence of disease which utilizes in-vitro toxicology testing. For instance, according to American Medical Association, a US-based organization for physicians, Health spending in the U.S. increased by 9.7% in the year 2020 to $4.1 trillion or $12,530 per capita. This growth rate is substantially higher than in 2019 (4.3 %). Therefore, the growing healthcare expenditure is driving the in-vitro toxicology testing market.

The development of innovative cell culture systems is a key trend gaining popularity in the in-vitro toxicology market. Major companies operating in the in-vitro toxicology testing market are focused on developing new technological solutions to strengthen their position. For instance, in August 2021, Amerigo Scientific, a US-based company operating in in-vitro toxicology testing launched 3D cell culture for scientific uses. This innovative vitro 3D cell culture technology offers a solution for precision medicine approaches that could host human and animal cells, making it a concrete solution for replacing and reducing small animal studies with both ethical and economic impacts in drug development.

In December 2021, Aragen Life Sciences Private Limited, an India-based R&D and manufacturing solutions provider acquired Intox Private Limited for an undisclosed amount. This acquisition helps Aragen to expand its integrated drug discovery and development toxicology services to pharmaceutical companies. Intox Private Limited is an India-based company operating in in-vitro toxicology testing.

The countries covered in the in-vitro toxicology testing market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The in-vitro toxicology testing market research report is one of a series of new reports from The Business Research Company that provides in-vitro toxicology testing market statistics, including in-vitro toxicology testing industry global market size, regional shares, competitors with an in-vitro toxicology testing market share, detailed in-vitro toxicology testing market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro toxicology testing industry. This in-vitro toxicology testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. In-vitro Toxicology Testing Market Characteristics

3. In-vitro Toxicology Testing Market Trends And Strategies

4. In-vitro Toxicology Testing Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On In-vitro Toxicology Testing Market
  • 4.2. Ukraine-Russia War Impact On In-vitro Toxicology Testing Market
  • 4.3. Impact Of High Inflation On In-vitro Toxicology Testing Market

5. In-vitro Toxicology Testing Market Size And Growth

  • 5.1. Global In-vitro Toxicology Testing Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global In-vitro Toxicology Testing Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. In-vitro Toxicology Testing Market Segmentation

  • 6.1. Global In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Consumables
  • Assays
  • Equipment
  • Software
  • Services
  • 6.2. Global In-vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Cellular Assays
  • Biochemical Assays
  • In Silico Models
  • Ex Vivo Models
  • 6.3. Global In-vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Cell Culture Technologies
  • High-Throughput Technologies
  • Toxicogenomics
  • 6.4. Global In-vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Neurotoxicity
  • Dermal toxicity
  • Cytotoxicity
  • Other Applications
  • 6.5. Global In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Pharmaceuticals and Biopharmaceuticals
  • Cosmetic and Household Products
  • Food
  • Chemicals

7. In-vitro Toxicology Testing Market Regional And Country Analysis

  • 7.1. Global In-vitro Toxicology Testing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global In-vitro Toxicology Testing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific In-vitro Toxicology Testing Market

  • 8.1. Asia-Pacific In-vitro Toxicology Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China In-vitro Toxicology Testing Market

  • 9.1. China In-vitro Toxicology Testing Market Overview
  • 9.2. China In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India In-vitro Toxicology Testing Market

  • 10.1. India In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan In-vitro Toxicology Testing Market

  • 11.1. Japan In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia In-vitro Toxicology Testing Market

  • 12.1. Australia In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia In-vitro Toxicology Testing Market

  • 13.1. Indonesia In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea In-vitro Toxicology Testing Market

  • 14.1. South Korea In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe In-vitro Toxicology Testing Market

  • 15.1. Western Europe In-vitro Toxicology Testing Market Overview
  • 15.2. Western Europe In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK In-vitro Toxicology Testing Market

  • 16.1. UK In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany In-vitro Toxicology Testing Market

  • 17.1. Germany In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France In-vitro Toxicology Testing Market

  • 18.1. France In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe In-vitro Toxicology Testing Market

  • 19.1. Eastern Europe In-vitro Toxicology Testing Market Overview
  • 19.2. Eastern Europe In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia In-vitro Toxicology Testing Market

  • 20.1. Russia In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America In-vitro Toxicology Testing Market

  • 21.1. North America In-vitro Toxicology Testing Market Overview
  • 21.2. North America In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA In-vitro Toxicology Testing Market

  • 22.1. USA In-vitro Toxicology Testing Market Overview
  • 22.2. USA In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America In-vitro Toxicology Testing Market

  • 23.1. South America In-vitro Toxicology Testing Market Overview
  • 23.2. South America In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil In-vitro Toxicology Testing Market

  • 24.1. Brazil In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East In-vitro Toxicology Testing Market

  • 25.1. Middle East In-vitro Toxicology Testing Market Overview
  • 25.2. Middle East In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa In-vitro Toxicology Testing Market

  • 26.1. Africa In-vitro Toxicology Testing Market Overview
  • 26.2. Africa In-vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa In-vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. In-vitro Toxicology Testing Market Competitive Landscape And Company Profiles

  • 27.1. In-vitro Toxicology Testing Market Competitive Landscape
  • 27.2. In-vitro Toxicology Testing Market Company Profiles
    • 27.2.1. Thermo Fisher Scientific Inc
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Merck KGaA
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Laboratory Corporation of America Holdings
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Gentronix Limited
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Bio-Rad Laboratories Inc
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The In-vitro Toxicology Testing Market

29. In-vitro Toxicology Testing Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦